Press Releases

WASHINGTON, Sept. 18 — Sen. Bernie Sanders (I-Vt.) delivered a speech on the floor of the United States Senate to discuss his intention to next week file Joint Resolutions of Disapproval (JRD) that would block the sale of more than $20 billion in offensive U.S. weaponry to Israel. The JRD is the only mechanism available to Congress to prevent an arms

This afternoon, Sanders will deliver speech on the floor of the Senate on the JRD WASHINGTON, Sept. 18 — Sen. Bernie Sanders (I-Vt.) today announced his intention to next week file Joint Resolutions of Disapproval (JRD) that would block the sale of offensive U.S. weaponry to Israel. The JRD is the only mechanism available to Congress to prevent an arms sale

Dr. Ralph de la Torre failed to comply with Congressional Subpoena WASHINGTON, Sept. 18 – In light of Steward CEO Dr. Ralph de la Torre’s failure to comply with the committee’s subpoena and absence from last week’s hearing, the Senate HELP Committee will vote this Thursday to adopt two resolutions: one for civil enforcement and another for certification to the

WASHINGTON, Sept. 17 – Ahead of next week’s hearing with Novo Nordisk CEO Lars Jørgensen, Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Health, Education, Labor, and Pensions Committee (HELP), today announced that CEOs of major generic pharmaceutical companies are willing to sell Ozempic to Americans for less than $100 per month at a profit. Novo Nordisk currently charges Americans with

WASHINGTON, Sept. 17 – Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), today held a discussion with experts on the outrageously high cost of diabetes and weight-loss drugs in America. At the meeting – which comes ahead of the committee hearing Sanders will be leading next week on the same issue –

Physicians and health professionals from around the country demanded that Novo Nordisk and Eli Lilly make their novel diabetes and obesity medications affordable and accessible to all. WASHINGTON, Sept. 16 – Ahead of next week’s hearing, which will focus on the outrageously high prices that Novo Nordisk charges Americans for their blockbuster drugs, Ozempic and Wegovy, Sen. Bernie Sanders (I-Vt.),